abstract |
Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR7, including those of Formula II: n n n n n n n n n n and pharmaceutically acceptable salts thereof, useful in treating HIV infections. |